49
Participants
Start Date
March 15, 2017
Primary Completion Date
February 27, 2018
Study Completion Date
March 14, 2023
FemBloc® Permanent Contraceptive System
The FemBloc Permanent Contraceptive System consists of treatment with a Delivery System and Biopolymer, and a confirmation test with the FemChec® Tubal Occlusion Confirmation device as part of a sonographic hysterosalpingogram (Sono HSG).
New York Presbyterian Hospital - Columbia University Medical Center, New York
University of North Carolina, Chapel Hill, Chapel Hill
Altus Research Inc., Lake Worth
Chattanooga Medical Research, Chattanooga
Lead Sponsor
Femasys Inc.
INDUSTRY